| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/25/2010 | US20100047867 Il-1 zeta, il-1 zeta splice variants and xrec2 dnas and polypeptides |
| 02/25/2010 | US20100047863 Group of novel enantiosleective microbial nitrile hydratases with broad substrate specificity |
| 02/25/2010 | US20100047846 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 02/25/2010 | US20100047838 Yeast genes that affect viral replication |
| 02/25/2010 | US20100047823 Polypeptides |
| 02/25/2010 | US20100047818 Diagnosis of carcinomas |
| 02/25/2010 | US20100047809 Pca3, pca3 genes, and methods of use |
| 02/25/2010 | US20100047805 Methods and compositions for targeted single-stranded cleavage and targeted integration |
| 02/25/2010 | US20100047797 Cytolethal distending toxins and detection of campylobacter bacteria using the same as a target |
| 02/25/2010 | US20100047780 Target and method for inhibition of bacterial rna polymerase |
| 02/25/2010 | US20100047772 Compounds, compositions and methods for the treatment of diseases characterized by a-33 related antigens |
| 02/25/2010 | US20100047770 Detection of Breast Cancer |
| 02/25/2010 | US20100047767 Pathogen binding |
| 02/25/2010 | US20100047764 Novel surface protein (HBsAg) variant of the hepatitis B virus |
| 02/25/2010 | US20100047428 Method for the extraction of one or several proteins in milk |
| 02/25/2010 | US20100047369 Anti-tumor drug, medicament, composition, and use thereof |
| 02/25/2010 | US20100047333 Modified Peptides and Their Use for the Treatment of Autoimmune Diseases |
| 02/25/2010 | US20100047305 Extracellular Matrix Compositions |
| 02/25/2010 | US20100047290 Functional protein crystals containing a core nano-particle and uses thereof |
| 02/25/2010 | US20100047287 Outer membrane vesicles and uses thereof |
| 02/25/2010 | US20100047285 Anticancer agents using verotoxin variants |
| 02/25/2010 | US20100047282 method of accelerated vaccination against ebola viruses |
| 02/25/2010 | US20100047280 Flavivirus ns1 subunit vaccine |
| 02/25/2010 | US20100047275 Peptide sequences and compositions |
| 02/25/2010 | US20100047273 Coxsackie B virus and type 1 diabetes |
| 02/25/2010 | US20100047268 Fusion proteins of hiv regulatory/accessory proteins |
| 02/25/2010 | US20100047267 Staphylococcus aureus proteins and nucleic acids |
| 02/25/2010 | US20100047266 Chimeric virus-like particles |
| 02/25/2010 | US20100047265 Active antiangiogenic therapy |
| 02/25/2010 | US20100047264 Immunogenic Affinity-Conjugated Antigen Systems Based on Papaya Mosaic Virus and Uses Thereof |
| 02/25/2010 | US20100047263 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto |
| 02/25/2010 | US20100047259 Follistatin domain containing proteins |
| 02/25/2010 | US20100047232 Modulators of neuronal regeneration |
| 02/25/2010 | US20100047225 Oligosaccharides comprising an aminooxy group and conjugates thereof |
| 02/25/2010 | US20100047171 Fusion Proteins That Contain Natural Junctions |
| 02/25/2010 | US20100047168 Soluble Zcytor 11 Cytokine Receptors |
| 02/25/2010 | US20100044230 Methods for separating carbon nanotubes |
| 02/25/2010 | DE102009036995A1 Matrix auf Kollagenbasis zur Verwendung als Restaurationsmaterial und Verfahren zur Herstellung derselben Collagen-based matrix for use as a restorative material and method of producing same |
| 02/25/2010 | CA2734838A1 T cell receptors and related materials and methods of use |
| 02/25/2010 | CA2734829A1 Artificial peptidoglycan lysing enzymes and peptidoglycan binding proteins |
| 02/25/2010 | CA2734734A1 Siderophore-mediated iron uptake in bacterial infection |
| 02/25/2010 | CA2734578A1 Antibodies to ccr2 |
| 02/25/2010 | CA2734515A1 Inhbb epitope peptides and vaccines containing the same |
| 02/25/2010 | CA2734467A1 Hig2 and urlc10 epitope peptide and vaccines containing the same |
| 02/25/2010 | CA2734124A1 Glycoprotein production method and screening method |
| 02/25/2010 | CA2733902A1 Human notch3 based fusion proteins as decoy inhibitors of notch3 signaling |
| 02/25/2010 | CA2733505A1 Plants having enhanced yield-related traits and a method for making the same |
| 02/25/2010 | CA2732773A1 Isolated polypeptides and polynucleotides useful for increasing nitrogen use efficiency, abiotic stress tolerance, yield and biomass in plants |
| 02/25/2010 | CA2732493A1 Genes, proteins and vectors for increaseing tolerance of plants and microbes to abiotic stresses and the use thereof |
| 02/25/2010 | CA2732423A1 Recombinantly produced human factor viii and ix |
| 02/25/2010 | CA2732337A1 Production of canola protein isolate without heat treatment ("c200ca") |
| 02/25/2010 | CA2731681A1 Soluble canola protein isolate production from protein micellar mass |
| 02/25/2010 | CA2730950A1 Preparation of canola protein isolate from canola oil seeds ("blendertein") |
| 02/24/2010 | EP2157192A1 Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (R-Spondins) |
| 02/24/2010 | EP2157175A1 Protein exhibiting activity of pyrethrin biosynthetic enzyme, gene endcoding the protein, and vector bearing the gene |
| 02/24/2010 | EP2157172A2 Plants having improved growth characteristics and methods for making the same |
| 02/24/2010 | EP2157101A1 HSP peptides and analogs for modulation of immune responses via antigen presenting cells |
| 02/24/2010 | EP2157100A1 Artificial peptidoglycan lysing enzymes and peptidoglycan binding proteins |
| 02/24/2010 | EP2157099A1 Novel immunoglobulin-binding proteins with improved specificity |
| 02/24/2010 | EP2157097A1 Specific binding agents of human angiopoietin-2 |
| 02/24/2010 | EP2156183A1 Prognostic assay for determining t cell response to hla antigens and use thereof in field of tissue transplantation |
| 02/24/2010 | EP2155878A2 A method of treating abnormal angiogenesis via the bai family of proteins and their protein fragments |
| 02/24/2010 | EP2155872A1 Tem8 peptides and vaccines comprising the same |
| 02/24/2010 | EP2155788A2 Cross-species-specific bispecific binders |
| 02/24/2010 | EP2155784A1 Chromatography process for obtaining a fviii/vwf complex with different ratios between the two proteins, for use in haemophilia a treatment and in von willebrand disease |
| 02/24/2010 | EP2155783A2 Cross-species-specific cd3-epsilon binding domain |
| 02/24/2010 | EP2155782A2 Mhc peptide complexes and uses thereof in infectious diseases |
| 02/24/2010 | EP2155781A1 Labelled adrenomedullin derivatives and their use for imaging and therapy. |
| 02/24/2010 | EP2155780A1 P53 peptide vaccine |
| 02/24/2010 | EP2155779A1 A process of aqueous protein extraction from brassicaceae oilseeds |
| 02/24/2010 | EP2155778A2 Detection of anaplasma platys |
| 02/24/2010 | EP2155247A1 Prevention of staphylococcus biofilm formation |
| 02/24/2010 | EP2155243A2 Compositions and methods comprising klk3, psca, or folh1 antigen |
| 02/24/2010 | EP2155232A2 Use of the augmenter of liver regeneration protein as an apoptosis regulator |
| 02/24/2010 | EP2155228A1 Polypeptide inhibitors of hsp27 kinase and uses therefor |
| 02/24/2010 | EP2155226A2 Compounds for inhibiting protein aggregation, and methods for making and using them |
| 02/24/2010 | EP2155206A1 Wound and cutaneous injury healing with a nucleic acid encoding a proteoglycan polypeptide |
| 02/24/2010 | EP2154946A2 Polynucleotides, polypeptides and methods for increasing oil content, growth rate and biomass of plants |
| 02/24/2010 | EP1869185B1 Conjugate comprising p21 protein for the treatment of cancer |
| 02/24/2010 | EP1721008B1 Diagnostic and therapeutic use of mal2 gene and protein for neurodegenerative diseases |
| 02/24/2010 | EP1687032B1 Pharmaceutical composition for treating unresectable, locally advanced pancreatic cancer (lapc). |
| 02/24/2010 | EP1644732B1 Animal model for the analysis of tumor metastasis |
| 02/24/2010 | EP1620061B1 Antiviral agents for the treatment, control and prevention of infections by coronaviruses |
| 02/24/2010 | EP1572066B1 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2 |
| 02/24/2010 | EP1553962B1 Combination chemotherapy with chlorotoxin |
| 02/24/2010 | EP1485481B1 Fluorescent protein from aequorea coerulescens and uses thereof |
| 02/24/2010 | EP1471936B1 Hiv vaccine and method of use |
| 02/24/2010 | EP1325130B1 Nogo receptor homologs |
| 02/24/2010 | EP1238113B1 Detection of lung neoplasms in stool |
| 02/24/2010 | EP1200607B1 Tet repressor-based transcriptional regulatory proteins |
| 02/24/2010 | EP0861261B9 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 02/24/2010 | CN101657466A Natural polypeptides for oral health care |
| 02/24/2010 | CN101654483A compositions and methods for generating chimeric heteromultimers |
| 02/24/2010 | CN101654480A Preparation method of enhanced artificial immunizing antigen of quinolone medicine mother nucleus |
| 02/24/2010 | CN101654479A Mammalian receptor proteins, agents, and methods relating thereto |
| 02/24/2010 | CN101654478A Soyabean protein glycosylation graft modification method |
| 02/24/2010 | CN101654477A Construction and application of mycobacterium tuberculosis fusion protein |
| 02/24/2010 | CN101653602A Treatment, prophylaxis and diagnostic reagent of hepatitis b |
| 02/24/2010 | CN101653594A Somatostatin-dopamine chimeric analogs |
| 02/24/2010 | CN100592086C Method for simultaneously detecting an antigen and an antibody of an infectious microorganism |